Related Experiment Video
Updated: May 8, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
BreakTrans: uncovering the genomic architecture of gene fusions
Abstract:
Producing gene fusions through genomic structural rearrangements is a major mechanism for tumor evolution. Therefore, accurately detecting gene fusions and the originating rearrangements is of great importance for personalized cancer diagnosis and targeted therapy. We present a tool, BreakTrans, that systematically maps predicted gene fusions to structural rearrangements. Thus, BreakTrans not only validates both types of predictions, but also provides mechanistic interpretations. BreakTrans effectively validates known fusions and discovers novel events in a breast cancer cell line. Applying BreakTrans to 43 breast cancer samples in The Cancer Genome Atlas identifies 90 genomically validated gene fusions. BreakTrans is available at http://bioinformatics.mdanderson.org/main/BreakTrans.
Insights
Detecting gene fusions and their originating genomic rearrangements is crucial for cancer diagnosis and therapy. BreakTrans is a new tool that links gene fusions to structural rearrangements, aiding in cancer research.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Gene fusions resulting from genomic structural rearrangements drive tumor evolution.
- Accurate detection of gene fusions and their originating rearrangements is vital for personalized cancer diagnosis and targeted therapy.
Purpose of the Study:
- To present BreakTrans, a computational tool designed to systematically map predicted gene fusions to their originating structural rearrangements.
- To validate gene fusion and structural rearrangement predictions and provide mechanistic interpretations.
Main Methods:
- Development and application of the BreakTrans tool.
- Systematic mapping of predicted gene fusions to structural rearrangements.
- Analysis of a breast cancer cell line and 43 The Cancer Genome Atlas (TCGA) breast cancer samples.
Main Results:
- BreakTrans successfully validated known gene fusions and identified novel events in a breast cancer cell line.
- Application to 43 breast cancer samples identified 90 genomically validated gene fusions.
- The tool provides mechanistic interpretations by linking gene fusions to specific structural rearrangements.
Conclusions:
- BreakTrans is an effective tool for validating gene fusions and structural rearrangements in cancer.
- The tool aids in understanding the mechanisms of tumor evolution and can support personalized cancer diagnosis and therapy.
- BreakTrans facilitates the discovery of novel genomic events in cancer.
Related Concept Videos
Overview of Transposition and Recombination
Gene Duplication and Divergence
The duplicated copies of the gene are called Paralogs. Paralogs with similar sequences and functions form a gene family. Across several species, a large number of gene families are characterized.
Tagging and Fusion Proteins
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Gene Conversion
Gene Conversion

